Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Clinique de Specialisee en Allergie de la Capitale

Québec, G1V 4W2, CanadaNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Asthma

Running trials

Active, not recruiting
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
NCT06572228· Phase 4· Regeneron Pharmaceuticals· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Clinique de Specialisee en Allergie de la Capitale: trial site – Frontlight Research